ストックスクリーナーアプリを入手
6.14
2.85%
-0.18
アフターアワーズ：
6.26
0.12
+1.95%
前日終値:
$6.32
開ける：
$6.38
24時間の取引高:
216.27K
Relative Volume:
0.96
時価総額：
$173.30M
収益：
$61.86M
当期純損益:
$-11.43M
株価収益率:
-12.74
EPS:
-0.4818
ネットキャッシュフロー:
$-12.52M
1週間 パフォーマンス:
-16.01%
1か月 パフォーマンス:
-18.46%
6か月 パフォーマンス:
-10.10%
1年 パフォーマンス:
-11.01%
1日の値動き範囲:
$6.09
$6.43
1週間の範囲:
$6.09
$7.525
52週間の値動き範囲:
$4.31
$9.555
Journey Medical Corp Stock (DERM) Company Profile
名前
Journey Medical Corp
セクター
電話
480-434-6670
住所
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, TEVA, HLN, ZTS, VTRS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
6.14 | 173.30M | 61.86M | -11.43M | -12.52M | -0.4818 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | 開始されました | H.C. Wainwright | Buy |
| 2025-07-30 | 再開されました | B. Riley Securities | Buy |
| 2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-28 | 再開されました | ROTH MKM | Buy |
| 2021-12-07 | 開始されました | B. Riley Securities | Buy |
Journey Medical Corp (DERM) 最新ニュース
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Are Options Traders Betting on a Big Move in Journey Medical Stock? - Yahoo Finance
EOCN Should I Buy - Intellectia AI
Journey Medical at H.C. Wainwright: emrosi drives growth - Investing.com
Journey Medical Corporation $DERM Shares Sold by Opaleye Management Inc. - marketbeat.com
Journey Medical Corporation to Participate in September 2026 Investor Conferences - Yahoo Finance
Shinon Healthcare Receives Honors at Sanjeevani 2026 for Medical Value Travel Leadership, Advancing the 'Heal in India' Vision - indiagazette.com
Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan
DERM Should I Buy - Intellectia AI
Journey Medical Corp (DERM) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Journey Medical Corp (DERM) Key Financial Ratios – Valuation, Profitability & More - Value Research
Audubon’s Globus Medical Acquires Duke Spinout Higgs Boson Health - BioBuzz
Journey Medical Corp (DERM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
536,000 Shares in Journey Medical Corporation $DERM Acquired by Punch & Associates Investment Management Inc. - MarketBeat
WeInfuse and 4U Medical Partner to Streamline the Infusion Patient Journey from Check-In to Care - Yahoo Finance
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy? - Yahoo Finance
DERM | Journey Medical Corporation Common FinancialsRevenue Breakdown - Quiver Quantitative
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction - Seeking Alpha
FY2026 EPS Estimates for Journey Medical Lowered by Analyst - MarketBeat
Teleconferência de Resultados do 2T26 da Journey Medical (FBIO): Receita cresce 23% com aceleração do Emrosi - TradingKey
Q3 EPS Estimates for Journey Medical Cut by HC Wainwright - MarketBeat
Conferencia de resultados del T2 de 2026 de Journey Medical (FBIO): los ingresos aumentan un 23% a medida que Emrosi se acelera - TradingKey
Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates - tradingkey.com
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
Analyst Reiterates Buy on Journey Medical as Emrosi Outperformance Supports Unchanged $13 Price Target - TipRanks
Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial - MarketBeat
Why is Journey Medical stock rallying today? - Investing.com
Why is Journey Medical stock rallying today? By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
A. G. P. Maintains Journey Medical(DERM.US) With Buy Rating, Cuts Target Price to $14 - Moomoo
Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM - MarketBeat
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Canada
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... - Yahoo Finance
DERM Looks 49.2% Overvalued on GF Value™ - GuruFocus
Journey Medical Releases Q2 2026 Financial Results - AlphaStreet
Journey Medical Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Journey Medical Q2 Earnings Call Highlights - MarketBeat
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings - Yahoo Finance
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Journey Medical tops Q2 2026 forecasts as stock rises - Investing.com
Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com
Journey Medical (NASDAQ:DERM) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Journey Medical (DERM) grows Emrosi sales but flags going concern risk - Stock Titan
Journey Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - finance.yahoo.com
Fortress Biotech Q2 Earnings Call Highlights - Yahoo Finance
Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Val - GuruFocus
Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Value Sees 6% Upside - Yahoo Finance
From the hardwood to healthcare: CEO Stephen Flatt’s journey to the top of long-term care - McKnight's Long-Term Care News
Journey Medical Corp expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Journey Medical Corp (DERM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Journey Medical Corp (DERM) 財務データ
収益
当期純利益
現金流量
EPS
0.18%
0.69%
大文字化:
|
ボリューム (24 時間):